Yehuda Handelsman: Received research grants, consultant and speaker honoraria from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Corcept, Eli Lilly, Ionis, Merck, Novo Nordisk, Regeneron, Sanofi, Verdiva Bio
It is important to understand that the key players evaluating their novel therapies in the pivotal and confirmatory trials should remain vigilant when selecting appropriate comparators to stand the greatest chance of a positive opinion from regulatory bodies, leading to approval, smooth launch, and rapid uptake
Sekeri-Pataryas, D
If you're planning a family, discuss timing with your PlexusDx prescriber so you can transition to safe alternatives or pause therapy appropriately
Consult Healthcare Providers: If fatigue persists beyond the initial adjustment period, it is advisable to consult with a healthcare provider